New research shows that subtle increases in blood sugar, even below diabetic levels, are more strongly linked to declines in men's sexual and reproductive health than age or testosterone, suggesting lifestyle and medical interventions targeting blood sugar could help preserve sexual function as men age.
A 28-year-old man with lifelong anorgasmia successfully achieved his first orgasm after being treated with flibanserin, a drug commonly known as 'female Viagra.' This case suggests that flibanserin could potentially be used to treat rare cases of anorgasmia in men, prompting calls for further clinical trials to evaluate its efficacy and safety.
Delayed ejaculation (DE), a common male sexual health problem affecting an estimated four percent of men, is often overlooked and poorly understood. Men with DE experience lower sexual satisfaction, relationship distress, anxiety, and general health issues. The causes of DE can range from childhood trauma to anxiety and shame around sex. Risk factors include age-related changes, declining testosterone levels, and type 1 diabetes. Mental distress, particularly anxiety, plays a significant role in DE. Treatment may involve addressing the root cause with the help of mental health experts, prescribing selective serotonin reuptake inhibitors (SSRIs), or administering testosterone or oxytocin. The stigma surrounding men's sexual health is gradually diminishing, leading to increased awareness and access to treatments.